Dewost hardens on Vinci role

Dewost, a former head at CDC, said: “With Leonard, Vinci is offering me a chance to contribute to the digital transformation of durable structures and move from bytes to concrete.

Karnataka cooks up $6.1bn startup centre

The artificial intelligence and data science-focused hub will aim to support 35,000 new jobs within five years.

Vietnam drafts VC framework

Vietnam startups currently attract VC investments of between $5,000 and $50,000, but no regulatory framework exists to provide clarity for investors.



Temasek incubator aims for life sciences success

The vehicle will aim to commercialise local startups and spinouts from Temasek Life Sciences Laboratory, a division of the firm’s philanthropic arm Temasek Trust.

AfDB backs African healthcare fund

African Development Bank is a limited partner in the $200m Rx Healthcare Fund, which will back companies that can help improve healthcare in Africa.

Russia-Saudi partnership registers $1bn fund

The vehicle is part of a $10bn agreement struck between RDIF and Public Investment Fund in 2015 which seeks to invest in Russian businesses.

Enterprise Ireland seeks experienced entrepreneurs

The latest competitive start fund will aim to lure seasoned business figures to redress the ecosystem’s imbalance that has favoured younger founders.



Big deal: Nucana and Nightstar race to public markets

Nucana, a Scottish Investment Bank-backed cancer treatment developer, and Nightstar Therapeutics, an Oxford spinout focused on retinal gene therapies, have entered the public market.

Kinova clasps onto $20m

Advanced robotics developer Kinova will use the funding to support an international expansion and lobby healthcare regulators to permit medical robotic products.

Tinubu squares $62.2m investment

Bpifrance has reinvested in the fintech developer as Long Arc Capital acquired a majority stake.

Omeicos gazes further into series B

The biopharmaceutical developer has opened an office in the US with the extension, which followed a first close backed by HTGF and KfW.

Vertex helps guide $12m towards Kryon

Automated robotics developer Kryon will use the capital to complete a software product for enterprises and to mount an expansion into international markets.

Nanotronics scopes out $30m ICD-led series D

Nanotronics’ total funding now stands at $71m and the company will use its latest round to expand in Asia and further develop its advanced microscopes.

Recursion racks up $60m series B

The money will be used to expand Recursion’s drug discovery program, which uses machine-learning to rapidly collect data for a diverse range of diseases.

Vertex visits Visterra to help close series C

Vertex is among the investors in Visterra’s series C round, which has now closed at $46.7m following a $23.6m second tranche.

Secret Escapes schedules $111m series D

GV-backed online travel marketplace Secret Escapes has collected $111m in equity and debt financing from investors including Singapore state-owned Temasek.

Palleon detects $47.6m series A

Palleon Pharmaceuticals has launched with $47.6m in series A funding to commercialise cancer therapies based on technology developed at Stanford and Dundee universities.

Deal net: 2 – 6 October 2017

The Global Government Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing government funds.